| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 44.83M | 51.87M | 90.98M | 164.31M | 320.52M | 326.25M |
| Gross Profit | -33.03M | -58.61M | -90.44M | -48.91M | 32.33M | 9.02M |
| EBITDA | -52.91M | -148.07M | -110.08M | 1.22M | 77.60M | 23.30M |
| Net Income | -167.12M | -139.24M | -93.08M | -68.15M | -36.94M | -17.24M |
Balance Sheet | ||||||
| Total Assets | 630.95M | 609.51M | 799.30M | 968.02M | 1.11B | 1.21B |
| Cash, Cash Equivalents and Short-Term Investments | 22.16M | 19.51M | 47.71M | 71.68M | 92.92M | 167.68M |
| Total Debt | 463.61M | 438.22M | 408.17M | 400.51M | 390.77M | 426.25M |
| Total Liabilities | 531.43M | 519.30M | 512.25M | 547.21M | 593.43M | 633.58M |
| Stockholders Equity | 502.37M | 601.22M | 764.05M | 851.21M | 917.48M | 954.27M |
Cash Flow | ||||||
| Free Cash Flow | -20.76M | -23.31M | -6.66M | -30.52M | -11.87M | 29.89M |
| Operating Cash Flow | -19.57M | -22.13M | 2.48M | -21.22M | 3.04M | 38.44M |
| Investing Cash Flow | -5.83M | -9.31M | -11.53M | 9.70M | -20.82M | -22.41M |
| Financing Cash Flow | 21.51M | 7.26M | -14.69M | -6.16M | -53.95M | -19.61M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
56 Neutral | HK$149.02M | 1.12 | -17.27% | ― | -17.96% | -95.06% | |
52 Neutral | HK$30.71M | 0.67 | ― | ― | -56.67% | ― | |
49 Neutral | HK$230.95M | -2.02 | -9.04% | ― | -33.99% | 42.25% | |
49 Neutral | HK$66.22M | 15.38 | 0.85% | ― | -5.06% | ― | |
48 Neutral | HK$301.31M | -54.55 | -395.28% | ― | -35.61% | 89.32% | |
41 Neutral | HK$12.09M | -0.08 | -49.13% | ― | -55.81% | -15292.41% |
Greenheart Group Limited has confirmed that all conditions under its first sale and purchase agreement (SPA 1) for a very substantial disposal of its sale assets have been satisfied, allowing the parties to move ahead to completion under the agreed terms. Completion of the second sale and purchase agreement (SPA 2) remains subject to the fulfilment or waiver of its conditions, including confirmation from the Māori Court, and the company said it will issue further announcements in due course on the transaction’s completion and the payment of a special dividend, developments that could reshape its asset base and return capital to shareholders.
The most recent analyst rating on (HK:0094) stock is a Hold with a HK$0.07 price target. To see the full list of analyst forecasts on Greenheart Group stock, see the HK:0094 Stock Forecast page.
Greenheart Group Limited, a company listed on the Hong Kong Stock Exchange, held a Special General Meeting (SGM) on November 24, 2025, where all proposed resolutions were unanimously approved by shareholders. The resolutions included the ratification of SPAs and the authorization of directors to execute necessary actions for these agreements, as well as the approval of a special cash dividend of HK$0.01 per share. This unanimous approval reflects strong shareholder support and could positively impact the company’s financial strategy and stakeholder relations.
Greenheart Group Limited has announced a special cash dividend of HKD 0.01 per share, subject to shareholder approval on November 24, 2025. This announcement follows a very substantial disposal of sale assets and reflects the company’s strategic financial decisions, potentially impacting its market positioning and shareholder value.
Greenheart Group Limited has announced a Special General Meeting (SGM) to be held on November 24, 2025, in Hong Kong. The meeting will address the approval of certain Share Purchase Agreements (SPAs) and the declaration of a special cash dividend of HK$0.01 per share, contingent upon specific conditions. These resolutions, if passed, are expected to impact the company’s operations and shareholder value positively.
Greenheart Group Limited has announced a further delay in the dispatch of a Circular related to its Disposal transaction, now expected by 7 November 2025. The completion of the transaction is contingent on certain conditions, and there is uncertainty regarding the declaration of a Special Dividend, urging shareholders to exercise caution.